Cellectis organizacji Zalecenie średnie
Jaka jest wartość Zalecenie średnie organizacji Cellectis?
Wartość Zalecenie średnie organizacji Cellectis to 1.50
Jaka jest definicja Zalecenie średnie?
Średnia rekomendacja to średnia ocen analityków dla akcji od 1,0 (silny zakup) do 5,0 (silny wzrost).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Zalecenie średnie firm w Health Care sektor na NASDAQ w porównaniu do Cellectis
Czym się zajmuję organizacja Cellectis?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Firmy z zalecenie średnie podobne do Cellectis
- Wartość Zalecenie średnie organizacji Activision Blizzard Inc to 1.48
- Wartość Zalecenie średnie organizacji Analog Devices to 1.48
- Wartość Zalecenie średnie organizacji CyberArk Software Ltd to 1.48
- Wartość Zalecenie średnie organizacji Peloton Interactive Inc to 1.48
- Wartość Zalecenie średnie organizacji Fidelity National Information Services to 1.49
- Wartość Zalecenie średnie organizacji Micron Technology to 1.49
- Wartość Zalecenie średnie organizacji Cellectis to 1.50
- Wartość Zalecenie średnie organizacji Nutrien Ltd to 1.52
- Wartość Zalecenie średnie organizacji TC to 1.52
- Wartość Zalecenie średnie organizacji Enbridge Inc to 1.52
- Wartość Zalecenie średnie organizacji Burlington Stores Inc to 1.52
- Wartość Zalecenie średnie organizacji Carmax Inc to 1.53
- Wartość Zalecenie średnie organizacji Ametek Inc to 1.53